HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,248,217 | +12.0% | 451,524 | +5.8% | 0.36% | +17.5% |
| Q2 2023 | $15,394,460 | -5.0% | 426,794 | +0.6% | 0.30% | -6.2% |
| Q1 2023 | $16,199,969 | -6.8% | 424,194 | +38.9% | 0.32% | -8.2% |
| Q4 2022 | $17,374,358 | -1.9% | 305,349 | -31.8% | 0.35% | -7.4% |
| Q3 2022 | $17,711,000 | -10.2% | 447,914 | -0.0% | 0.38% | -3.6% |
| Q2 2022 | $19,713,000 | -9.6% | 448,014 | -18.1% | 0.39% | +9.7% |
| Q1 2022 | $21,803,000 | -0.8% | 546,715 | 0.0% | 0.36% | +9.5% |
| Q4 2021 | $21,983,000 | +16.2% | 546,715 | +17.6% | 0.33% | +13.1% |
| Q3 2021 | $18,913,000 | -10.4% | 464,930 | 0.0% | 0.29% | -8.5% |
| Q2 2021 | $21,112,000 | +23.0% | 464,930 | +12.9% | 0.32% | +15.3% |
| Q1 2021 | $17,164,000 | -2.4% | 411,695 | 0.0% | 0.28% | -7.7% |
| Q4 2020 | $17,583,000 | +44.7% | 411,695 | -10.9% | 0.30% | +25.2% |
| Q3 2020 | $12,149,000 | -3.0% | 462,300 | -1.1% | 0.24% | -5.9% |
| Q2 2020 | $12,527,000 | +47.9% | 467,265 | -0.7% | 0.25% | +25.9% |
| Q1 2020 | $8,469,000 | +79.0% | 470,750 | +76.4% | 0.20% | +139.3% |
| Q4 2019 | $4,732,000 | – | 266,895 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |